- Windlas Biotech is all set to launch its initial public offering (IPO) in the first week of August.
- The company provides pharmaceutical development services and large-scale manufacturing services.
- It is looking to raise ₹402 crore at the upper price band of ₹460.
Windlas Biotech has announced to come up with its initial public offering (IPO) on August 4 with a price band of ₹448-460. The company is looking to raise ₹402 crore on its upper price band.
The company is a pharmaceutical formulations contract development and manufacturing organisation (
CDMO). It provides pharmaceutical development services and large-scale manufacturing services.
The offer comprises ₹165 crore of fresh issue and offer for sale upto 51.42 lakh.
Here are the important details to note:Issue details
|
|
Price band
| ₹448 to ₹460
|
IPO open date
| August 4
|
IPO close date
| August 6
|
Allotment date
| August 11
|
Initiation of refunds
| August 12
|
Credit of shares to demat account
| August 13
|
IPO listing date
| August 17
|
Minimum lot
| 30
|
Source: Company release Currently, the company has 4 manufacturing facilities located at Dehradun in Uttarakhand.
Proceeds from the IPO will be utilised in purchase of equipments required for capacity expansion of existing facility at
Dehradun Plant IV, addition of injectables dosage capability at its existing facility at
Dehradun Plant II (₹50 crore), working capital requirements (₹47.5 crore), repayment of debt of ₹20 crore and for general corporate purposes.
Particulars
| FY21
| FY20
| FY19
|
Profits
| ₹15.5 crore
| ₹16.2 crore
| ₹63.8 crore
|
Revenue
| ₹427.6 crore
| ₹328.8 crore
| ₹307.2 crore
|
Total borrowings
| ₹31.3 crore
| ₹27.4 crore
| ₹29.9 crore
|
SEE ALSO:
>$4
$4$4$4$4$4$4$4$4$4$4$4$4$4$4$4$4